Compare JAKK & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JAKK | OSUR |
|---|---|---|
| Founded | 1995 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 211.9M | 214.1M |
| IPO Year | 1996 | 2000 |
| Metric | JAKK | OSUR |
|---|---|---|
| Price | $20.52 | $3.14 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $35.00 | $3.00 |
| AVG Volume (30 Days) | 161.8K | ★ 431.4K |
| Earning Date | 05-28-2026 | 05-28-2026 |
| Dividend Yield | ★ 4.92% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $331,249,000.00 | $167,064,000.00 |
| Revenue This Year | $9.46 | $4.48 |
| Revenue Next Year | $4.36 | $7.76 |
| P/E Ratio | $23.63 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.87 | $2.08 |
| 52 Week High | $26.49 | $4.22 |
| Indicator | JAKK | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 54.88 | 60.96 |
| Support Level | $19.53 | $3.05 |
| Resistance Level | $21.61 | $3.31 |
| Average True Range (ATR) | 1.12 | 0.17 |
| MACD | -0.13 | 0.02 |
| Stochastic Oscillator | 54.81 | 85.42 |
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.